<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Department of Psychopharmacology</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/212FBA96-7037-4D15-818A-22ECC6A7E6A8"><gtr:id>212FBA96-7037-4D15-818A-22ECC6A7E6A8</gtr:id><gtr:firstName>Anne</gtr:firstName><gtr:surname>Lingford-Hughes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C67373B7-D390-4D49-BD31-1280BA65D1F5"><gtr:id>C67373B7-D390-4D49-BD31-1280BA65D1F5</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Nutt</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0B7BA49E-A505-41DC-AB71-A59E5DEB972E"><gtr:id>0B7BA49E-A505-41DC-AB71-A59E5DEB972E</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Grasby</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7B26620B-FEB9-4EF6-884F-8670FC59E3D6"><gtr:id>7B26620B-FEB9-4EF6-884F-8670FC59E3D6</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Brooks</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400575"><gtr:id>FCF8012F-C079-4365-993E-5C7C1268B97B</gtr:id><gtr:title>Neurotransmitters in opiate and alcohol addiction</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400575</gtr:grantReference><gtr:abstractText>Heroin and alcohol addiction have massive impacts on modern society, causing severe medical, psychological and social problems with their associated costs including increased use of medical resources, lost working hours and increases in crime and public disorder. In the last two decades there has been a big increase in the number of people addicted to drugs and alcohol but treatments have not kept pace with this. To try to improve this situation we are working to understand the brain processes that lead to addiction. We know that drugs including alcohol act by changing chemical messengers in the brain called neurotransmitters. Our study tries to show how these are altered in people addicted to heroin or alcohol. We also want to understand how treatments work, so we also study the effects that current treatments have in the brain to help design new and better ones. 

This work will continue our successful previous research which uses the newest scanning technique, positron emission tomography (PET). This allows us to directly measure levels of neurotransmitters and their receptors in the human brain. We focus on three key neurotransmitters in addiction- the dopamine system involved in mediating pleasure, the opiate system which mediates many effects of opiate drugs such as heroin and also the pleasurable effects of alcohol, and lastly the GABA system, the brain?s natural calming system that mediates many effects of alcohol. 

We rely on our patients or users to volunteer for our studies and we regularly meet with them to inform them about how the research is going and to discuss with them interpretation and relevance of the results. 

As well as publishing our work in scientific journals and giving presentations at national and international conferences we also give lectures to the public about our research and the science underpinning it. Bristol University is committed to public education in science and has a Professor specifically for this ? the Collier Professor of Public Understanding of Science (at present Kathy Sykes of BBC s Rough Science). She has already worked with us in several local community meetings on addiction. Members of our research team often appear on local and national radio and TV to talk about advances in understanding of addiction, and take part in meetings with school children and their parents to give guidance on risks and realities of drug and alcohol use.</gtr:abstractText><gtr:technicalSummary>This is a major 5-year grant that uses state-of-the-art PET neuroimaging plus pharmacological challenge and gene analysis to test critical theories about brain mechanisms that underlie addiction to, and pleasure from, alcohol and opiates (heroin). The role of three key neurotransmitter and receptor systems will be evaluated:? GABA, dopamine and endogenous opioids (endorphins) using PET tracers, 11C-Ro 15-4513 and 11C-flumazenil for GABA-A, 11C-raclopride for dopamine and 11C-diprenorphine for the opioid system. Specifically we shall test the following theories that 
1) GABA 
a) the alpha5 subtype of the GABA-A receptor is involved in alcohol and opiate dependence 
b) the new selective tracer 11C-Ro15-4513 can be used to measure synaptic GABA concentrations in living human brain, to allow investigation of whether alcohol increases GABA function. 
2) Dopamine 
a) the release of dopamine in the striatum relates to the expectation of heroin and not to its direct pharmacological action 
b) the lower the density of dopamine D2 receptors the greater the pleasurable effect of substances 
c) alterations in brain endorphin systems are a common feature of withdrawal from both opiates and alcohol and contribute to craving and relapse.</gtr:technicalSummary><gtr:fund><gtr:end>2011-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1464548</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>presentation at CFS meeting in 2016\</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FA30B3B2-2BF4-4D34-AAA0-5142B932A134</gtr:id><gtr:impact>british sleep society meeting

more interviews - and public lectures eg cafe scientifiques</gtr:impact><gtr:outcomeId>69A28A7EEAD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Disseminating information about the MARC scheme</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>672B6D91-70A7-4ABC-88B0-D5A3D88B7351</gtr:id><gtr:impact>Presented MARC scheme, its aims and opportunities. Presented at RCPsych Addictions Faculty Meeting 2016 as well as other regional meetings alongside presentation of research outputs from other grants</gtr:impact><gtr:outcomeId>58c113634c56d7.46017246</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.imperial.ac.uk/medicine/mrc-addiction-research-clinical-training/</gtr:url><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>mrc</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>F933694C-6750-4085-8DE8-A3C86F8B563B</gtr:id><gtr:impact>showed applicaitons and opportunities for translational research</gtr:impact><gtr:outcomeId>7E195565D89</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>vlaidation of 11C-ro154513 as an alpha-5 selctive GABA-A receptor tracer in humans</gtr:description><gtr:id>D9C62AA9-2631-4AB6-8A54-B7B23A177DB4</gtr:id><gtr:impact>lower binding in the brainms of alcoholics especially in brain regions relating to addiction and memory</gtr:impact><gtr:outcomeId>18D40A95577</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>pet tracer</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F479D833-3A7A-48CA-9E46-89CC24AF4B36</gtr:id><gtr:title>Assessment of GABAA benzodiazepine receptor (GBzR) sensitivity in patients with alcohol dependence.</gtr:title><gtr:parentPublicationTitle>Alcohol and alcoholism (Oxford, Oxfordshire)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74e33b6e6c73fb34506ed6a3ffcaa967"><gtr:id>74e33b6e6c73fb34506ed6a3ffcaa967</gtr:id><gtr:otherNames>Taylor C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0735-0414</gtr:issn><gtr:outcomeId>2D43D7A003F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F507EE14-03F0-4506-AA24-53A7D375D94C</gtr:id><gtr:title>Neuropharmacology of addiction and how it informs treatment.</gtr:title><gtr:parentPublicationTitle>British medical bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdb2a9c9fc56464edeebc94d8161093c"><gtr:id>fdb2a9c9fc56464edeebc94d8161093c</gtr:id><gtr:otherNames>Lingford-Hughes A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-1420</gtr:issn><gtr:outcomeId>545a5b39c52279.38259140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E006D51F-0EA5-4A83-825E-94DF430149CA</gtr:id><gtr:title>Characterisation of the contribution of the GABA-benzodiazepine a1 receptor subtype to [(11)C]Ro15-4513 PET images.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31f031541d02146a4189f199542c5a26"><gtr:id>31f031541d02146a4189f199542c5a26</gtr:id><gtr:otherNames>Myers JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>pm_13654_24_22214903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30BE0C57-1850-4819-AEBF-0B9BC3BC3A24</gtr:id><gtr:title>Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: an [11C]diprenorphine PET study.</gtr:title><gtr:parentPublicationTitle>European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac842786439e217b7106b717ca6d425c"><gtr:id>ac842786439e217b7106b717ca6d425c</gtr:id><gtr:otherNames>Williams TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0924-977X</gtr:issn><gtr:outcomeId>b61rkn9DwBU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CFDA22D-286D-422B-A18C-EA5844593C79</gtr:id><gtr:title>Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3844d2e4191ceba4697c082897237ad4"><gtr:id>3844d2e4191ceba4697c082897237ad4</gtr:id><gtr:otherNames>Carhart-Harris RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>6F2E496FFBB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F62CFE82-7BAC-4812-B82D-DA5EBCC7E38B</gtr:id><gtr:title>Opioids and anxiety.</gtr:title><gtr:parentPublicationTitle>Journal of psychopharmacology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac374eaf02bb39818ac1a7a6da55fb05"><gtr:id>ac374eaf02bb39818ac1a7a6da55fb05</gtr:id><gtr:otherNames>Colasanti A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0269-8811</gtr:issn><gtr:outcomeId>545a5b38b282b1.10752523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DADFC7E7-FEB2-46A9-9E3C-AEE309D7DE96</gtr:id><gtr:title>GABAB receptors in addiction and its treatment.</gtr:title><gtr:parentPublicationTitle>Advances in pharmacology (San Diego, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd88b8d24130045ac130004f202c5857"><gtr:id>dd88b8d24130045ac130004f202c5857</gtr:id><gtr:otherNames>Tyacke RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1054-3589</gtr:issn><gtr:outcomeId>WZ7ivdSMevX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDB23314-CCE8-42A8-B9AC-77F85A09C10F</gtr:id><gtr:title>Striatal dopamine D2/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd6b47e5a50a1922a22eb25838e6d775"><gtr:id>fd6b47e5a50a1922a22eb25838e6d775</gtr:id><gtr:otherNames>Clark L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>545a5b3c1dd8f1.38506014</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D873994-5AE3-44F1-B72E-B5AC0097D043</gtr:id><gtr:title>Imaging alcohol cue exposure in alcohol dependence using a PET 15O-H2O paradigm: results from a pilot study.</gtr:title><gtr:parentPublicationTitle>Addiction biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c8164a415046134aebb488fa1f0b3c1"><gtr:id>3c8164a415046134aebb488fa1f0b3c1</gtr:id><gtr:otherNames>Lingford-Hughes AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1355-6215</gtr:issn><gtr:outcomeId>FCCC5C9F6A2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C232156-9AD8-4C43-B889-76523F82C732</gtr:id><gtr:title>World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.</gtr:title><gtr:parentPublicationTitle>The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e523c8faa8de5f7e8ae0517ee9b9f31"><gtr:id>5e523c8faa8de5f7e8ae0517ee9b9f31</gtr:id><gtr:otherNames>Soyka M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1562-2975</gtr:issn><gtr:outcomeId>TxT6xaN1CBz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00C6134A-8862-4EA0-B744-A2050577D75E</gtr:id><gtr:title>Does alcohol increase the risk of overdose death: the need for a translational approach.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6a21002105f03f66eed67137e868864"><gtr:id>b6a21002105f03f66eed67137e868864</gtr:id><gtr:otherNames>Hickman M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>rxm46qytKMk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1AE5BD8-8706-49B7-8F79-E62AB15F6625</gtr:id><gtr:title>Differences between magnetoencephalographic (MEG) spectral profiles of drugs acting on GABA at synaptic and extrasynaptic sites: a study in healthy volunteers.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/334c9136b2450fe695b3b016b3d6b265"><gtr:id>334c9136b2450fe695b3b016b3d6b265</gtr:id><gtr:otherNames>Nutt D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>545a5984be8536.02675520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7263FAB-812B-44B7-9A04-5C27237E6D17</gtr:id><gtr:title>A proof-of-concept study using [11C]flumazenil PET to demonstrate that pagoclone is a partial agonist.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdb2a9c9fc56464edeebc94d8161093c"><gtr:id>fdb2a9c9fc56464edeebc94d8161093c</gtr:id><gtr:otherNames>Lingford-Hughes A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>44481D547BA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DB25539-BF1A-4CE5-8995-6C583B710093</gtr:id><gtr:title>A [11C]Ro15 4513 PET study suggests that alcohol dependence in man is associated with reduced a5 benzodiazepine receptors in limbic regions.</gtr:title><gtr:parentPublicationTitle>Journal of psychopharmacology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdb2a9c9fc56464edeebc94d8161093c"><gtr:id>fdb2a9c9fc56464edeebc94d8161093c</gtr:id><gtr:otherNames>Lingford-Hughes A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0269-8811</gtr:issn><gtr:outcomeId>545a5b397c24e5.32164184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>699D7C80-FE82-405F-8E50-DBBD2C19B45A</gtr:id><gtr:title>Development of a rational scale to assess the harm of drugs of potential misuse.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/334c9136b2450fe695b3b016b3d6b265"><gtr:id>334c9136b2450fe695b3b016b3d6b265</gtr:id><gtr:otherNames>Nutt D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>2A88CBA2A4F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C85B5B0-DB07-4915-9AB8-037561E29784</gtr:id><gtr:title>Acute increases in synaptic GABA detectable in the living human brain: a [&amp;sup1;&amp;sup1;C]Ro15-4513 PET study.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ef610bf70a2414f028fadc10f8091b2"><gtr:id>9ef610bf70a2414f028fadc10f8091b2</gtr:id><gtr:otherNames>Stokes PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>545a5b40479715.03464404</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDC0AA54-2BBD-46F3-99AF-C6BC3D1A4EA9</gtr:id><gtr:title>Alcohol and Relatively Pure Cannabis Use, but Not Schizotypy, are Associated with Cognitive Attenuations.</gtr:title><gtr:parentPublicationTitle>Frontiers in psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2405be3c82991b503e7b1467e88160f"><gtr:id>b2405be3c82991b503e7b1467e88160f</gtr:id><gtr:otherNames>Herzig DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1664-0640</gtr:issn><gtr:outcomeId>545a5984e70782.71212165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8104A67D-29BE-41C8-B9E4-F5DB168CC6E3</gtr:id><gtr:title>Effects of acute tyrosine/phenylalanine depletion on the selective processing of smoking-related cues and the relative value of cigarettes in smokers.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b4764e7c307b8a7be6428da092184ae"><gtr:id>9b4764e7c307b8a7be6428da092184ae</gtr:id><gtr:otherNames>Hitsman B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>7A01962DA2E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F26CF145-311A-4F10-9352-EA2778F60AB8</gtr:id><gtr:title>The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET study.</gtr:title><gtr:parentPublicationTitle>Synapse (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c96b400aeea3c97556675137070e681c"><gtr:id>c96b400aeea3c97556675137070e681c</gtr:id><gtr:otherNames>Montgomery AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0887-4476</gtr:issn><gtr:outcomeId>E802DD30F2D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E2F395F-E553-4A50-8F81-61693E387D36</gtr:id><gtr:title>Brain dopamine response in human opioid addiction.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45e9f0f6abb0711e7ad24db09196af60"><gtr:id>45e9f0f6abb0711e7ad24db09196af60</gtr:id><gtr:otherNames>Daglish MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>Sh2YUMxn2ZS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DE53238-64A8-4EA6-8CE6-F83AF7AD1A6E</gtr:id><gtr:title>Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ebc5f1341b86df7fd71794875b2749b"><gtr:id>5ebc5f1341b86df7fd71794875b2749b</gtr:id><gtr:otherNames>Nutt DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>E9A7B572B63</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DADE648-848F-4F62-8B01-885B22ABF251</gtr:id><gtr:title>Effects of cannabis use on outcomes of psychotic disorders: systematic review.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f789e6d88055ac8e0b025813050e8aa"><gtr:id>4f789e6d88055ac8e0b025813050e8aa</gtr:id><gtr:otherNames>Zammit S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>MS9Ajt7wEPv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F398E8D-DD3F-4940-BFFB-44AEBEA1E04E</gtr:id><gtr:title>Opiate agonists and antagonists modulate taste perception in opiate-maintained and recently detoxified subjects.</gtr:title><gtr:parentPublicationTitle>Journal of psychopharmacology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4e5e248878a874673b0e17efd75d4d0"><gtr:id>e4e5e248878a874673b0e17efd75d4d0</gtr:id><gtr:otherNames>Green A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-8811</gtr:issn><gtr:outcomeId>pm_13654_24_23364815</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>824BF11D-4BAE-40B1-BF76-0AD3E4ED9F0E</gtr:id><gtr:title>Using [11C]diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: clinical and preclinical studies.</gtr:title><gtr:parentPublicationTitle>The Journal of pharmacology and experimental therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1306d16bedaa7bb38996e009e78c30b"><gtr:id>f1306d16bedaa7bb38996e009e78c30b</gtr:id><gtr:otherNames>Melichar JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-3565</gtr:issn><gtr:outcomeId>866CFDD1079</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>662572E4-D66A-4FB1-8929-AC9F59A83D3E</gtr:id><gtr:title>Addiction: the clinical interface.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/334c9136b2450fe695b3b016b3d6b265"><gtr:id>334c9136b2450fe695b3b016b3d6b265</gtr:id><gtr:otherNames>Nutt D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>US7TbzYm1iM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA8EF5FC-C8C6-42E6-8A27-0A00E98E0183</gtr:id><gtr:title>Anne Lingford-Hughes: to get into addiction, just say yes.</gtr:title><gtr:parentPublicationTitle>The lancet. Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25717321b2b67901393ba7e142718aba"><gtr:id>25717321b2b67901393ba7e142718aba</gtr:id><gtr:otherNames>Mitchell F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2215-0366</gtr:issn><gtr:outcomeId>58c11211ea89f3.11614764</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F354A2E9-152E-4B92-8EB1-7CB1D11B7F48</gtr:id><gtr:title>Is socioeconomic status in early life associated with drug use? A systematic review of the evidence.</gtr:title><gtr:parentPublicationTitle>Drug and alcohol review</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f1c89af17e4957c39625fff683d2a8e"><gtr:id>8f1c89af17e4957c39625fff683d2a8e</gtr:id><gtr:otherNames>Daniel JZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-5236</gtr:issn><gtr:outcomeId>GacJZc1MVxE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5064E77E-26F3-48F4-ABD6-B69CDF16F7AF</gtr:id><gtr:title>Reduced thalamic grey matter volume in opioid dependence is influenced by degree of alcohol use: a voxel-based morphometry study.</gtr:title><gtr:parentPublicationTitle>Journal of psychopharmacology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2970e905a18b09a6cfc4717bca033fb"><gtr:id>d2970e905a18b09a6cfc4717bca033fb</gtr:id><gtr:otherNames>Reid AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0269-8811</gtr:issn><gtr:outcomeId>1D73EB7AD40</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>708DF77C-9CAE-4F3A-81A1-9CEB57230944</gtr:id><gtr:title>Imaging endogenous opioid peptide release with [11C]carfentanil and [3H]diprenorphine: influence of agonist-induced internalization.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab6b183b25736a83c820747a14448aff"><gtr:id>ab6b183b25736a83c820747a14448aff</gtr:id><gtr:otherNames>Quelch DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>545a5b408b1414.55435512</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DE8533D-8D8F-4CDD-B568-66F6FDA34CD2</gtr:id><gtr:title>GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c8164a415046134aebb488fa1f0b3c1"><gtr:id>3c8164a415046134aebb488fa1f0b3c1</gtr:id><gtr:otherNames>Lingford-Hughes AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>DBB4D54F590</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBDFAF88-1A5C-4082-BFA9-E5F2D3616F1B</gtr:id><gtr:title>Measurement of GABA using J-difference edited 1H-MRS following modulation of synaptic GABA concentration with tiagabine.</gtr:title><gtr:parentPublicationTitle>Synapse (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31f031541d02146a4189f199542c5a26"><gtr:id>31f031541d02146a4189f199542c5a26</gtr:id><gtr:otherNames>Myers JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0887-4476</gtr:issn><gtr:outcomeId>545a5b3fee5694.02710616</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58B19F4C-339C-465D-B89C-96F99C590959</gtr:id><gtr:title>Low sensitivity of the positron emission tomography ligand [11C]diprenorphine to agonist opiates.</gtr:title><gtr:parentPublicationTitle>The Journal of pharmacology and experimental therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbad80373fdbee489ab1415c2a130266"><gtr:id>cbad80373fdbee489ab1415c2a130266</gtr:id><gtr:otherNames>Hume SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3565</gtr:issn><gtr:outcomeId>BC189A323E2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3B0D372-7869-4BAB-BC87-4E3871BB3943</gtr:id><gtr:title>History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability.</gtr:title><gtr:parentPublicationTitle>Journal of psychopharmacology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ef610bf70a2414f028fadc10f8091b2"><gtr:id>9ef610bf70a2414f028fadc10f8091b2</gtr:id><gtr:otherNames>Stokes PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0269-8811</gtr:issn><gtr:outcomeId>545a5b3a71b6b3.24607667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC4E848A-2EBA-43ED-A09F-FF7F3941F621</gtr:id><gtr:title>Investigating expectation and reward in human opioid addiction with [(11) C]raclopride PET.</gtr:title><gtr:parentPublicationTitle>Addiction biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c125bf00e8b99982bcddb77b4bf18c4"><gtr:id>9c125bf00e8b99982bcddb77b4bf18c4</gtr:id><gtr:otherNames>Watson BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1355-6215</gtr:issn><gtr:outcomeId>pm_13654_24_23829344</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0219BFCB-6CF0-4FE2-B817-1AA6784F7DBE</gtr:id><gtr:title>Influence of agonist induced internalization on [3H]Ro15-4513 binding-an application to imaging fluctuations in endogenous GABA with positron emission tomography.</gtr:title><gtr:parentPublicationTitle>Synapse (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a904b8999280c6c344895077ff4e55a8"><gtr:id>a904b8999280c6c344895077ff4e55a8</gtr:id><gtr:otherNames>Quelch D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0887-4476</gtr:issn><gtr:outcomeId>545a5b40b52504.91711347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CECE30F0-8965-43E9-8E68-4546BF305156</gtr:id><gtr:title>Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ef610bf70a2414f028fadc10f8091b2"><gtr:id>9ef610bf70a2414f028fadc10f8091b2</gtr:id><gtr:otherNames>Stokes PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>gGVYt9xXzDn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE9ED95A-144A-4A83-96FA-33358B1C04E7</gtr:id><gtr:title>History of cigarette smoking is associated with higher limbic GABAA receptor availability.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ef610bf70a2414f028fadc10f8091b2"><gtr:id>9ef610bf70a2414f028fadc10f8091b2</gtr:id><gtr:otherNames>Stokes PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>pm_13654_24_23247185</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400575</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>2472941E-25F2-45EC-A735-3C0872CE6B26</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.3  Psychological, social and economic factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>